WallStreetZenWallStreetZen

NASDAQ: SNSE
Sensei Biotherapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SNSE

Based on 1 analyst offering 12 month price targets for Sensei Biotherapeutics Inc

Min Forecast
$30.00+244.83%
Avg Forecast
$30.00+244.83%
Max Forecast
$30.00+244.83%

Should I buy or sell SNSE stock?

Based on 1 analyst offering ratings for Sensei Biotherapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SNSE stock forecasts and price targets.

SNSE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-05

1 of 1

Forecast return on equity

Is SNSE forecast to generate an efficient return?

Company
-80.52%
Industry
265.17%
Market
229.18%
SNSE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SNSE forecast to generate an efficient return on assets?

Company
-67.15%
Industry
92.7%
SNSE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SNSE earnings per share forecast

What is SNSE's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$18.98
Avg 2 year Forecast
-$10.28
Avg 3 year Forecast
-$12.68

SNSE revenue forecast

What is SNSE's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

SNSE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SNSE$8.70$30.00+244.83%Buy
PPCB$0.83N/AN/A
CLDI$1.50N/AN/A
BOLT$5.27$7.00+32.83%Buy
GOVX$0.40$6.00+1,400.00%Strong Buy
View Top Biotech Stocks

Sensei Biotherapeutics Stock Forecast FAQ

Is Sensei Biotherapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SNSE) stock is to Buy SNSE stock.

Out of 1 analyst, 0 (0%) are recommending SNSE as a Strong Buy, 1 (100%) are recommending SNSE as a Buy, 0 (0%) are recommending SNSE as a Hold, 0 (0%) are recommending SNSE as a Sell, and 0 (0%) are recommending SNSE as a Strong Sell.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.

What is SNSE's earnings growth forecast for 2025-2027?

(NASDAQ: SNSE) Sensei Biotherapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 45.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.83%.

Sensei Biotherapeutics's earnings in 2025 is -$24,139,000.On average, 4 Wall Street analysts forecast SNSE's earnings for 2025 to be -$23,935,626, with the lowest SNSE earnings forecast at -$23,534,662, and the highest SNSE earnings forecast at -$24,063,521. On average, 4 Wall Street analysts forecast SNSE's earnings for 2026 to be -$12,961,647, with the lowest SNSE earnings forecast at -$18,602,766, and the highest SNSE earnings forecast at -$6,754,208.

In 2027, SNSE is forecast to generate -$15,991,391 in earnings, with the lowest earnings forecast at -$15,364,278 and the highest earnings forecast at -$16,461,726.

What is SNSE's revenue growth forecast for 2025-2027?

(NASDAQ: SNSE) Sensei Biotherapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 103.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.

Sensei Biotherapeutics's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast SNSE's revenue for 2025 to be $0, with the lowest SNSE revenue forecast at $0, and the highest SNSE revenue forecast at $0. On average, 3 Wall Street analysts forecast SNSE's revenue for 2026 to be $0, with the lowest SNSE revenue forecast at $0, and the highest SNSE revenue forecast at $0.

In 2027, SNSE is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is SNSE's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SNSE) forecast ROA is -67.15%, which is lower than the forecast US Biotechnology industry average of 92.7%.

What is SNSE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SNSE price target, the average SNSE price target is $30.00, with the highest SNSE stock price forecast at $30.00 and the lowest SNSE stock price forecast at $30.00.

The Wall Street analyst predicted that Sensei Biotherapeutics's share price could reach $30.00 by Aug 5, 2026. The average Sensei Biotherapeutics stock price prediction forecasts a potential upside of 244.83% from the current SNSE share price of $8.70.

What is SNSE's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SNSE) Sensei Biotherapeutics's current Earnings Per Share (EPS) is -$19.13. On average, analysts forecast that SNSE's EPS will be -$18.98 for 2025, with the lowest EPS forecast at -$18.66, and the highest EPS forecast at -$19.08. On average, analysts forecast that SNSE's EPS will be -$10.28 for 2026, with the lowest EPS forecast at -$14.75, and the highest EPS forecast at -$5.36. In 2027, SNSE's EPS is forecast to hit -$12.68 (min: -$12.18, max: -$13.05).

What is SNSE's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SNSE) forecast ROE is -80.52%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.